Neumora Therapeutics (NMRA) Institutional Ownership → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free NMRA Stock Alerts $9.19 -0.58 (-5.94%) (As of 05/10/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Neumora Therapeutics (NASDAQ:NMRA)CurrentInstitutional OwnershipPercentage47.65%Number ofInstitutional Buyers(last 12 months)16TotalInstitutional Inflows(last 12 months)$177.52MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$641.08K Get NMRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Neumora Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NMRA Institutional Buying and Selling by Quarter Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Neumora Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/10/2024Vanguard Group Inc.334,330$4.60M0.0%-12.2%0.210% 5/3/2024 Callan Capital LLC204,987$2.82M0.2%N/A0.129% 5/1/2024 Auour Investments LLC105,087$1.45M0.5%N/A0.066% 4/23/2024 Addis & Hill Inc314,821$4.19M3.6%N/A0.198% 4/22/2024 Windmill Hill Asset Management Ltd26,121$359K0.1%N/A0.016% 2/14/2024Avidity Partners Management LP1,990,632$33.94M1.2%+10.6%1.304% 2/13/2024Tower Research Capital LLC TRC2,558$44K0.0%N/A0.002% 2/6/2024 Amalgamated Bank1,709$29K0.0%N/A0.001% 2/1/2024 New York State Common Retirement Fund6,900$118K0.0%N/A0.005% 1/30/2024Strs Ohio3,200$54K0.0%N/A0.002% 1/12/2024 SG Americas Securities LLC6,308$108K0.0%N/A0.004% 12/6/2023Citigroup Inc.14,416$203K0.0%N/A0.009% 11/15/2023Laurion Capital Management LP21,557$304K0.0%N/A0.014% 11/14/2023Soros Fund Management LLC10,000$141K0.0%N/A0.007% 11/14/2023Avidity Partners Management LP1,800,000$25.40M1.0%N/A1.179% 11/13/2023FMR LLC5,624,353$79.36M0.0%N/A3.683% 11/9/2023Johnson & Johnson912,128$12.87M4.7%N/A0.597% 10/23/2023 WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST3,309,124$46.69M0.6%N/A2.178% (Data available from 1/1/2016 forward) NMRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NMRA shares? During the previous two years, 17 institutional investors and hedge funds held shares of Neumora Therapeutics. The most heavily invested institutionals were FMR LLC ($79.36M), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST ($46.69M), Avidity Partners Management LP ($33.94M), Johnson & Johnson ($12.87M), Vanguard Group Inc. ($4.60M), Addis & Hill Inc ($4.19M), and Callan Capital LLC ($2.82M).Learn more on NMRA's institutional investors. What percentage of Neumora Therapeutics stock is owned by institutional investors? 47.65% of Neumora Therapeutics stock is owned by institutional investors. Learn more on NMRA's institutional investor holdings. Which institutional investors have been buying Neumora Therapeutics stock? Of the 16 institutional investors that purchased Neumora Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($5.62M), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST ($3.31M), Avidity Partners Management LP ($1.99M), Johnson & Johnson ($912.13K), Addis & Hill Inc ($314.82K), Callan Capital LLC ($204.99K), and Auour Investments LLC ($105.09K). How much institutional buying is happening at Neumora Therapeutics? Institutional investors have bought a total of 12,553,901 shares in the last 24 months. This purchase volume represents approximately $177.52M in transactions. Which Neumora Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Neumora Therapeutics stock in the last 24 months: Vanguard Group Inc. ($46.62K). How much institutional selling is happening at Neumora Therapeutics? Institutional investors have sold a total of 46,624 shares in the last 24 months. This volume of shares sold represents approximately $641.08K in transactions. Related Companies: ADMA Biologics Institutional Ownership Sana Biotechnology Institutional Ownership 4D Molecular Therapeutics Institutional Ownership Inhibrx Institutional Ownership Fusion Pharmaceuticals Institutional Ownership Tarsus Pharmaceuticals Institutional Ownership Vir Biotechnology Institutional Ownership Beam Therapeutics Institutional Ownership Cullinan Oncology Institutional Ownership Scholar Rock Institutional Ownership This page (NASDAQ:NMRA) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsGold Set to EXPLODE!Gold Safe ExchangeDems have chosen Biden replacement?Paradigm PressGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neumora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.